We are live on ! Find out more
NEOS

Neos Therapeutics, Inc
NEOS

Delisted

NEOS was delisted on the 19th of March, 2021.

Back to rankings

49 hedge funds and large institutions have $14.6M invested in Neos Therapeutics, Inc in 2020 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 11 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 11

9% less funds holding

Funds holding: 54 → 49 (-5)

29% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 7

55% less capital invested

Capital invested by funds: $32.7M → $14.6M (-$18.1M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $8K

Holders
49
Holders Change
-5
Holders Change %
-9.26%
% of All Funds
1.08%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
11
Reduced
11
Closed
7
Calls
–
Puts
$8K
Net Calls
-$8K
Net Calls Change
+$15K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$47.2K
2
Citadel Advisors
Citadel Advisors
Florida
+$47.1K
3
Goldman Sachs
Goldman Sachs
New York
+$44.9K
4
Millennium Management
Millennium Management
New York
+$31.9K
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$29.1K

Top Sellers

Rank Fund Capital Flow
1
SFM
Sphera Funds Management
Israel
-$1.4M
2
Russell Investments Group
Russell Investments Group
United Kingdom
-$874K
3
Boston Partners
Boston Partners
Massachusetts
-$347K
4
SCM
Stonepine Capital Management
Oregon
-$232K
5
JP Morgan Chase
JP Morgan Chase
New York
-$144K
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
26
Southport Capital Management
Tennessee
$18K – – –
State Street
27
State Street
Massachusetts
$18K – – –
TRCT
28
Tower Research Capital (TRC)
New York
$18K +$8.91K +6,485 +36%
AG
29
Algert Global
California
$17K -$15.4K -11,230 -33%
Charles Schwab
30
Charles Schwab
California
$16K – – –
CIBC Private Wealth Group
31
CIBC Private Wealth Group
Georgia
$12K – – –
Susquehanna International Group
32
Susquehanna International Group
Pennsylvania
$12K +$21.1K +15,359 New
Victory Capital Management
33
Victory Capital Management
Texas
$12K +$22.5K +16,368 New
Bank of New York Mellon
34
Bank of New York Mellon
New York
$10K – – –
Commonwealth Equity Services
35
Commonwealth Equity Services
Massachusetts
$10K – – –
Bank of America
36
Bank of America
North Carolina
$8K – – –
RJA
37
Raymond James & Associates
Florida
$8K – – –
SCA
38
Stonebridge Capital Advisors
Minnesota
$8K – – –
UBS Group
39
UBS Group
Switzerland
$6K +$3.67K +2,669 +53%
Osaic Holdings
40
Osaic Holdings
Arizona
$4K +$6.03K +4,390 New
Royal Bank of Canada
41
Royal Bank of Canada
Ontario, Canada
$3K -$5.5K -4,000 -49%
Citigroup
42
Citigroup
New York
$1K – – –
TFGT
43
TS Financial Group (TSFG)
Illinois
$1K – – –
BNP Paribas Financial Markets
44
BNP Paribas Financial Markets
France
$195 – – –
Russell Investments Group
45
Russell Investments Group
United Kingdom
– -$874K -580,391 Closed
Boston Partners
46
Boston Partners
Massachusetts
– -$347K -229,485 Closed
JP Morgan Chase
47
JP Morgan Chase
New York
– -$144K -95,590 Closed
OAM
48
Oxford Asset Management
United Kingdom
– -$136K -90,202 Closed
Deutsche Bank
49
Deutsche Bank
Germany
– -$17K -11,661 Closed
MAM
50
Meeder Asset Management
Ohio
– -$11K -7,568 Closed
1
2
3

NEOS Hedge Fund Activity: Q1 2020 in Review

49 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Neos Therapeutics, Inc (NEOS) for Q1 2020, worth a combined $14.6M — down 55% from $32.7M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of NEOS and 5 opened new positions — a net loss of 2 holders — while 11 trimmed existing stakes and 11 added.

The largest buyer was Renaissance Technologies, adding an estimated $47.2K. The largest seller was Sphera Funds Management, cutting an estimated $1.4M.

  • 49 institutional investors held Neos Therapeutics, Inc (NEOS) as of Q1 2020, down from 54 in Q4 2019.
  • Funds reported $14.6M of Neos Therapeutics, Inc stock for Q1 2020, down 55% quarter-over-quarter.
  • 5 funds opened new Neos Therapeutics, Inc positions in Q1 2020 and 7 closed out, a net change of -2 holders.
  • The largest Neos Therapeutics, Inc buyer in Q1 2020 was Renaissance Technologies, an estimated $47.2K added.
  • The largest Neos Therapeutics, Inc seller in Q1 2020 was Sphera Funds Management, an estimated $1.4M sold.

Based on aggregated 13F filings for Q1 2020.